The PX1 Research PT-141 peptide calculator provides precise volumetric and concentration mathematics for laboratory reconstitution procedures. Designed for researchers working with lyophilized melanocortin agonists, this tool standardizes milligram-to-microliter conversions to maintain experimental consistency across in vitro and preclinical models.
The PX1 Research PT-141 peptide calculator provides precise volumetric and concentration mathematics for laboratory reconstitution procedures. Designed for researchers working with lyophilized melanocortin agonists, this tool standardizes milligram-to-microliter conversions to maintain experimental consistency across in vitro and preclinical models.
A PT-141 peptide calculator determines the final concentration of a reconstituted sample by dividing the total mass of the lyophilized peptide (in milligrams) by the volume of diluent introduced (in milliliters). For example, introducing 2.0 mL of bacteriostatic water into a vial containing 10 mg of high-purity PT-141 yields a working stock concentration of 5.0 mg/mL (or 5.0 µg/µL).
To calculate micro-volumetric aliquots for laboratory instruments or calibrated syringe units, multiply the target mass requirement by the total diluent volume and divide by the total vial mass. Precise volumetric calculations are critical when preparing assays to evaluate melanocortin receptor activation profiles without introducing stock-concentration variance.
PT-141, chemically designated as Bremelanotide, is a synthetic cyclic heptapeptide derivative of alpha-melanocyte-stimulating hormone (α-MSH). Its chemical structure consists of the amino acid sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH, featuring a molecular weight of approximately 1024.2 g/mol. Unlike linear peptide chains, its cyclic core confers resistance against rapid enzymatic degradation by circulating endopeptidases during preclinical observation.
Researchers evaluating structural biology can examine the synthesized compound within our catalog of all peptides. PT-141 was specifically engineered to isolate central signaling mechanisms while minimizing peripheral skin-pigmentation side effects observed in early α-MSH analogs. For complete biochemical specifications, visit the primary PT-141 product page.
Preclinical investigations demonstrate that PT-141 acts as a non-selective agonist primarily targeting melanocortin receptors MC3R and MC4R within the central nervous system. Unlike nitric oxide donors or phosphodiesterase type 5 (PDE5) inhibitors that operate downstream on vascular smooth muscle tissues, PT-141 exerts its primary effects by binding to hypothalamic receptors involved in neuroendocrine signaling.
In animal models, activation of central MC4R pathways by PT-141 has been shown to modulate dopaminergic pathways within the medial preoptic area (mPOA) of the brain. Data from rodent studies indicate that this central activation initiates behavioral responses associated with sexual-health pathways without altering direct systemic vascular resistance. Additional background on melanocortin pathways can be explored in our research library hub.
To standardize stock solution preparation, researchers utilize two core mathematical formulas governing mass-volume-concentration relationship:
1. Stock Concentration (C) = Total Mass (m) / Total Diluent Volume (V)
2. Required Liquid Volume (v) = Target Research Mass / Stock Concentration (C)
When calculating values for a standard 10 mg lyophilized vial using 2.5 mL of sterile laboratory diluent, the resulting concentration is 4.0 mg/mL (10 mg ÷ 2.5 mL). If an assay protocol specifies a 200 µg (0.2 mg) sample target, the required micro-volumetric draw is 0.05 mL (50 µL or 5 units on a standard U-100 micro-syringe). Utilizing standardized calculations prevents pipetting discrepancies across multi-well benchtop trials.
Laboratory liquid handling typically relies on high-precision micro-pipettes calibrated in microliters (µL) or specialized U-100 micro-syringes calibrated in graduate units. Understanding the volumetric equivalent per unit is essential for assay accuracy:
• 1.0 mL = 1000 µL = 100 Units (on a U-100 scale)
• 0.1 mL = 100 µL = 10 Units
• 0.01 mL = 10 µL = 1 Unit
If a stock solution is reconstituted to 2.0 mg/mL (20 µg per µL), a single unit on a U-100 syringe represents 10 µL, which yields exactly 200 µg of active peptide compound. Maintaining systematic volumetric records is standard practice in ISO-compliant laboratories working with custom research compounds.
PT-141 belongs to a distinct class of synthetically modified melanocortin receptor agonists. Comparing its receptor binding affinities with structural analogs assists laboratories in selecting the appropriate molecule for specific signaling assays.
When evaluated alongside Melanotan II, PT-141 exhibits a reduced binding affinity for the MC1R subtype, which reduces melanogenesis signaling while isolating central neural pathways. Conversely, compounds like Setmelanotide demonstrate high selectivity for MC4R, making them primary targets for metabolic research rather than neuro-behavioral studies. Reviewing these comparative binding profiles helps researchers delineate specific receptor interactions during cell culture trials.
Reconstitution protocols require appropriate diluents depending on the scheduled length of the experimental run. For short-term single-use in vitro assays, sterile 0.9% sodium chloride (normal saline) or sterile water for injection (WFI) is suitable. However, for multi-use laboratory protocols extending over several days, bacteriostatic water containing 0.9% benzyl alcohol is required to inhibit microbial proliferation.
During diluent introduction, direct stream impact onto the lyophilized cake should be avoided. Researchers should direct the diluent stream against the glass wall of the vial, allowing liquid to run down slowly. Gently swirl the vial until complete dissolution occurs. Mechanical shaking must be avoided, as high shear forces can cause peptide denaturation or aggregate formation.
Lyophilized PT-141 maintains optimal chemical stability when stored in dark, desiccated environments at temperatures between -20°C and -80°C. Under these conditions, the peptide cake remains viable for extended storage durations.
Once reconstituted into liquid solution, PT-141 should be kept refrigerated at 2°C to 8°C. At these temperatures, bacteriostatic stock solutions remain stable for up to 30 days. To avoid freeze-thaw degradation—which breaks peptide bonds and accelerates degradation—liquid aliquots intended for long-term storage should be flash-frozen at -80°C and thawed only once immediately prior to assay execution.
Experimental reproducibility depends entirely on compound purity and consistency. PX1 Research subjects every production lot of PT-141 to rigorous testing protocols performed by independent ISO 17025 accredited laboratories in the United States.
Our analytical verification framework includes high-performance liquid chromatography (RP-HPLC) to verify chemical purity (>99%), liquid chromatography-mass spectrometry (LC-MS) to confirm exact molecular weight, and kinetic chromogenic LAL assays to ensure endotoxin levels remain strictly below <0.05 EU/mg. Every shipment includes a lot-specific Certificate of Analysis (COA) to support compliance in academic and industrial laboratory settings. Institutional buyers can apply for dedicated purchasing structures through our wholesale lab accounts.
What formula is used in a PT-141 peptide calculator?
The primary formula is C = m / V, where C represents final concentration (mg/mL or µg/µL), m is the mass of the lyophilized peptide (mg), and V is the volume of reconstituted liquid diluent (mL).
How much bacteriostatic water should be added to a 10 mg PT-141 vial?
Common laboratory reconstitutions add 2.0 mL or 2.5 mL of bacteriostatic water to a 10 mg vial, resulting in stock concentrations of 5.0 mg/mL (50 µg/µL) or 4.0 mg/mL (40 µg/µL), respectively.
What is the primary mechanism of action of PT-141 in research models?
PT-141 acts as a central melanocortin receptor agonist (primarily MC3R and MC4R) within the central nervous system, modulating neuroendocrine signaling and behavioral response pathways in preclinical animal models.
How should reconstituted PT-141 be stored in the laboratory?
Reconstituted liquid solutions must be refrigerated at 2°C to 8°C and protected from light. Solutions preserved with 0.9% benzyl alcohol remain stable for up to 30 days under refrigeration.
How does PT-141 differ structurally from Melanotan II?
PT-141 (Bremelanotide) is a carboxylic acid metabolite derived from Melanotan II. It lacks the C-terminal amide group of MT-2, which significantly reduces its affinity for MC1R while retaining potency at MC3R and MC4R.
What analytical tests verify the purity of PX1 Research peptides?
Every lot is verified using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for purity, Mass Spectrometry (MS) for identity verification, and Endotoxin Testing (LAL assay) to confirm levels below established laboratory safety limits.
Can PT-141 be frozen after reconstitution?
Yes, reconstituted stock can be aliquoted and frozen at -20°C or -80°C for extended stability. Repeated freeze-thaw cycles must be avoided to prevent protein degradation.
Are PX1 Research compounds intended for human use?
No. All products supplied by PX1 Research are strictly intended for laboratory research, in vitro assays, and preclinical animal models. They are not intended for human or veterinary administration.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.